/ Our Company/Board of Directors Stanley M. Bergman Chairman of the Board and Chief Executive Officer Since 1989, Stanley M. Bergman has been Chairman of the Board and CEO of Henry Schein, Inc., a Fortune 500™ company and the world's largest provider of health care products and services to office-based dental, animal health, and medical practitioners, with more than 21,000 Team Schein Members and operations or affiliates in 32 countries. Henry Schein is a member of the S&P 500® and Nasdaq 100® indexes. In 2016, the Company's sales reached a record $11.6 billion. Henry Schein has been a Fortune World's Most Admired Company for 16 consecutive years. Read more » Barry J. Alperin Retired Vice Chairman, Hasbro, Inc.; Member of the Board of Directors of Fiesta Restaurant Group, Inc., Jefferies Group LLC, K'NEX Industries, Inc. and Weeks Marine, Inc. Lawrence S. Bacow, Ph.D. Leader-in-Residence, Center for Public Leadership at Harvard's Kennedy School of Government; Member and Chair of the Joint Committee on Inspection, Harvard Corporation; Member of the Board of Directors of Liquidnet Holdings, Inc. and Loews Corporation Gerald A. Benjamin Executive Vice President, Chief Administrative Officer James P. Breslawski President, Henry Schein, Inc., and CEO, Global Dental Group, Member of the Board of Directors Paul Brons Former Member of the Board of Management of Akzo Nobel, N.V., Former President of Organon International BV Joseph L. Herring Former Chief Executive Officer Covance, Inc. and Member of the Board of Directors of the University Medical Center of Princeton Donald J. Kabat Former Chief Financial Officer of Central Park Skaters, Inc.; Former President of D.J.K. Consulting Services, Inc.; Retired Partner, Accenture PLC Ireland; and Member of the Board of Directors for several not-for-profit organizations Kurt P. Kuehn Former Chief Financial Officer of United Parcel Service, Inc. and Member of the Board of Directors of NCR Corporation Philip A. Laskawy Lead Director, Henry Schein, Inc., Retired Chairman, Ernst & Young, LLP (now known as EY LLP), and Member of the Board of Directors of Lazard Ltd. and Loews Corporation Mark E. Mlotek Executive Vice President, Chief Strategic Officer, Member of the Board of Directors Steven Paladino Executive Vice President, Chief Financial Officer, Member of the Board of Directors Carol Raphael Senior Advisor for Manatt Health Solutions; Former President and CEO, Visiting Nurse Service of New York; Member of the Board of Directors of the New York eHealth Collaborative E. Dianne Rekow, DDS, Ph.D. Former Dean of the Dental Institute at King's College London and Professor of Orthodontics; Former Professor of Orthodontics, Senior Vice Provost of Engineering Technology and Provost of Polytechnic Institute at New York University Bradley T. Sheares, Ph.D. Former CEO, Reliant Pharmaceuticals and Former President of U.S. Human Health for Merck & Co., Member of the Board of Directors of Honeywell International and The Progressive Corporation Chairman of the Board and Chief Executive Officer Since 1989, Stanley M. Bergman has been Chairman of the Board and CEO of Henry Schein, Inc., a Fortune 500™ company and the world's largest provider of health care products and services to office-based dental, animal health, and medical practitioners, with more than 21,000 Team Schein Members and operations or affiliates in 32 countries. Henry Schein is a member of the S&P 500® and Nasdaq 100® indexes. In 2016, the Company's sales reached a record $11.6 billion. Henry Schein has been a Fortune World's Most Admired Company for 16 consecutive years. Mr. Bergman serves as a board member or advisor for numerous institutions including New York University College of Dentistry; the University of Pennsylvania School of Dental Medicine; the Columbia University Medical Center; University of the People; Hebrew University; Tel Aviv University; the University of the Witwatersrand Fund; The World Economic Forum's Health Care Governors; the Business Council for International Understanding, the Japan Society and the Metropolitan Opera. Mr. Bergman is an honorary member of the American Dental Association and the Alpha Omega Dental Fraternity. Stan is the recipient of the Ellis Island Medal of Honor; the CR Magazine Corporate Responsibility Lifetime Achievement Award; the 2017 CEO of the Year award by Chief Executive Magazine; Honorary Doctorates from The University of the Witwatersrand, Hofstra University, A.T. Still University's Arizona School of Dentistry and Oral Health, Case Western Reserve University and Farmingdale State College (SUNY); and Honorary Fellowship from King's College London - Dental Institute and the International College of Dentists. Stan and Marion Bergman and their family are active supporters of organizations fostering the arts, higher education, cultural diversity and grassroots health care and sustainable entrepreneurial economic development initiatives in the United States, Africa and other developing regions of the world. Mr. Bergman is a graduate of The University of the Witwatersrand in South Africa, and is a South African Chartered Accountant and a NYS Certified Public Accountant (CPA). Articles The People Have Spoken. Now We Must Move Forward. Why Civility Matters Now. How Will Generation Z Change Our World? Of Moccasins and Locomotives: The Priceless Gifts of My Great Mentors. I've Had the Same Job for 25 Years. Here's What I've Learned. From Apartheid to Today's Divided Politics, This is Why We Need Responsive Leadership. Videos Stanley Bergman Accepts CEO of the Year Award from Chief Executive Magazine Stanley Bergman on CNBC: 'Anything to Do With Digital' is Growing Rapidly in Health Care Stanley Bergman on Fox Business News: Keeping Americans Out of Hospitals Through Wellness and Prevention Stanley Bergman on CNBC: Regulations Should be Equal Throughout the World Stanley Bergman on CNBC Africa: World Economic Forum in Davos Henry Schein CEO: Staying Strong | Mad Money | CNBC. Henry Schein CEO: Digital Transformation | Mad Money | CNBC. Retired Vice Chairman, Hasbro, Inc.; Member of the Board of Directors of Fiesta Restaurant Group, Inc., Jefferies Group LLC, K'NEX Industries, Inc. and Weeks Marine, Inc. Mr. Alperin has been a director of the Company since May 1996. Mr. Alperin, who was an attorney in New York City before joining Hasbro, Inc. in 1985, has been a private consultant since August 1995. He served in various senior executive officer positions and ultimately as Vice Chairman of Hasbro, Inc. from 1985 until his retirement in 1995. He served as a director of Seaman Furniture Company, Inc., a furniture retailing company, from 1992 to February 2001. He currently serves as a director of two additional publicly traded companies, K-Sea Transportation Partners, L.P., and The Hain Celestial Group, Inc., and of K'nex Brand, LLC, a private toy manufacturer, and Weeks Marine, Inc., a private company in the marine construction industry. He also serves on the Board for Fiesta Restaurant Group, Inc., as well as on the Board for Jefferies Group LLC. Among his many non-profit activities, Mr. Alperin serves as a trustee and member of the Executive Committee of The Caramoor Center for Music and the Arts, and is President Emeritus of the Board of The Jewish Museum and Immediate Past President of the Board of the New York Chapter of the American Jewish Committee. He also formerly served as Chairman of the Board of Visitors of the Tucker Foundation at Dartmouth College; President of the Board of the Stanley M. Isaacs Neighborhood Center in New York City; a trustee of the Hasbro Children's Foundation; and a member of the Columbia Health Sciences Advisory Council. Leader-in-Residence, Center for Public Leadership at Harvard's Kennedy School of Government; Member and Chair of the Joint Committee on Inspection, Harvard Corporation; Member of the Board of Directors of Liquidnet Holdings, Inc. and Loews Corporation Dr. Bacow has been a director of the Company since December 2014 and is currently Leader-in-Residence at the Center for Public Leadership at Harvard's Kennedy School of Government. Dr. Bacow is also a member of the Harvard Corporation, the fiduciary oversight board of Harvard University, where he chairs the Joint Committee on Inspection, which functions as Harvard University's audit committee. From 2001 to 2011, Dr. Bacow was the 12th President of Tufts University, where he oversaw all seven of the University's schools, including its School of Dental Medicine, School of Medicine and the Cummings School of Veterinary Medicine. In addition, he served on the Board of Trustees and as a member of the executive committee of Tufts Medical Center. Following Tufts, Dr. Bacow served as President-in-Residence in the Higher Education Program at Harvard's Graduate School of Education for three years. Earlier in his career, Dr. Bacow spent 24 years on the faculty at the Massachusetts Institute of Technology, where he held the Lee and Geraldine Martin Professorship of Environmental Studies. He also served as the elected Chair of the MIT Faculty and subsequently as Chancellor, one of the Institute's two most senior academic officers. In addition to serving on Henry Schein's Board, Dr. Bacow is on the Board of Overseers of TIAA-CREF, and is a Director of Liquidnet and Loews Corporation, serving on the audit committee of both Boards. He is also a past Director of Boston Properties, Inc., where he was a member of the audit committee and the compensation committee. Dr. Bacow received an S.B. in economics from the Massachusetts Institute of Technology, a J.D. from Harvard Law School, and a M.P.P. and a Ph.D. from Harvard's Kennedy School of Government. He is a Fellow of the American Academy of Arts and Sciences and the recipient of five honorary degrees. Executive Vice President, Chief Administrative Officer Mr. Benjamin is now in his 28th year with Henry Schein, Inc. He has been Executive Vice President and Chief Administrative Officer of Henry Schein, Inc. since February 2000. He also serves as a member of the Company's Board of Directors, the CEO's Executive Management Committee, and the Company's liaison to the Board's Compensation Committee. In his current position, Mr. Benjamin directs the Company's Global Services functions throughout North America, Europe, Asia, Australia and New Zealand. These functions include all aspects of the Supply Chain (Distribution, Inventory Management and Transportation), Human Resources, Information Services, Customer Services, Security, and Financial Operations. Under Henry Schein's global distribution operations, Mr. Benjamin manages 4.5 million square feet of distribution space from which over 14 million orders are shipped annually, with inventory buys of over $6 billion worldwide. Under Mr. Benjamin's leadership, the Company has led the industry in worldwide distribution efficiency and accuracy. Mr. Benjamin also guides all aspects of human resources and organizational development, with more than 19,000 Team Schein Members in 32 countries around the world. In addition to spearheading innovative professional development initiatives, Mr. Benjamin has ensured that the Company's unique values-based culture has been preserved and strengthened as the organization has experienced exponential growth through scores of strategic global acquisitions. This culture is marked by Henry Schein's commitment to social responsibility. Mr. Benjamin currently sits as a Board of Director of the Henry Schein Cares Foundation, the Company's global social responsibility program, and has directed all internally driven programs for Henry Schein Cares including Back to School and Holiday Cheer for Children, two annual flagship programs that give back to the less fortunate. In 2014, Mr. Benjamin was honored as an Ellis Island Medal of Honor recipient for founding "Henry Schein Cares" and for his support of YAI (Young Adult Institute) which serves individuals with disabilities. Mr. Benjamin was also honored for his work with MCW (Miracle Corners of the World) which empowers young people to become positive agents for change in their communities. Prior to joining the Company, Mr. Benjamin served in a series of positions with increasing responsibility in 12 years with Estée Lauder, Inc., leaving that company as Director of Material Planning & Control. Mr. Benjamin earned a bachelor's degree in Electrical Engineering at the City College of New York, and an MBA in Marketing at Fordham University at Lincoln Center. President, Henry Schein, Inc., and CEO, Global Dental Group, Member of the Board of Directors Mr. Breslawski is now in his 36th year with Henry Schein, Inc., a Fortune® 500 company and the world's largest provider of health care products and services to office-based dental, animal health, and medical practitioners. He is currently President of Henry Schein, Inc. and Chief Executive Officer of Henry Schein's Global Dental Group, as well as a member of the Company's Executive Management Committee and a member of the Henry Schein Board of Directors. Before assuming his current position, Mr. Breslawski held a number of key roles with increasing responsibility throughout the Company, including Executive Vice President and President of Henry Schein Dental, the Company's U.S. Dental business; Chief Financial Officer; Vice President of Finance and Administration; and Vice President and Controller. Prior to joining Henry Schein, Mr. Breslawski was a certified public accountant at the national professional services firm BDO Seidman, LLP (now known as BDO USA, LLP). He received his degree in accounting from St. John's University. In addition to being a New York State certified public accountant, Mr. Breslawski is a member of the American Institute of Certified Public Accountants and the New York State Society of Certified Public Accountants. He is currently a Member of the Leadership Council at Harvard School of Dental Medicine. He previously has served as a Member of the Board of Governors for St. John's University; a Trustee of the Long Island University Board; and a Board Member of the National Foundation of Dentistry for the Handicapped. Mr. Breslawski also has served as Chairman of the Board of the American Dental Trade Association, Chairman of the Board of the Dental Trade Alliance Foundation and President of the Dental Dealers of America. Former Member of the Board of Management of Akzo Nobel, N.V., Former President of Organon International BV Mr. Brons has been a director of the Company since April 2005. A member of the Akzo Nobel Board of Management from 1994-2002, he led all of the company's pharmaceutical business units, including human and veterinary pharmaceuticals, OTCs, generics, diagnostics and pharmaceutical active ingredients. Since retiring from the Akzo Nobel N.V. Board of Management in 2002, Mr. Brons has served on the Supervisory Boards for Akzo Nobel Netherlands; Organon BioSciences Netherlands; and IBM Corporation Netherlands. He was honored in 1996 by Her Majesty the Queen with the decoration of Knight of the Order of Lion of the Kingdom of the Netherlands, the country's highest civilian order, conferred for his meritorious achievements for Akzo Nobel and other international activities. Former Chief Executive Officer Covance, Inc. and Member of the Board of Directors of the University Medical Center of Princeton Mr. Herring has been a director of the Company since May 2016. He was Chief Executive Officer of Covance, Inc. from February to July 2015. From 2005 to February 2015, Mr. Herring served as Chief Executive Officer of Covance, Inc. and as Chairman of its Board of Directors from 2006 until its acquisition by Laboratory Corporation of America, Inc., in February 2015. Prior to joining Covance, Mr. Herring held a variety of senior leadership positions with Caremark International and American Hospital Supply Corporation over the course of his 19 years with the combined companies. He currently serves on the nonprofit board for University Medical Center of Princeton and previously served on the board of the Association of Clinical Research Organizations, of which he served as chairman. During the past five years, Mr. Herring served as a director of Covance Inc. He is a former director of Team Health Holdings Inc., a provider of outsourced physician staffing solutions. Mr. Herring received a Bachelor of Science in Marketing from Louisiana State University. Former Chief Financial Officer of Central Park Skaters, Inc.; Former President of D.J.K. Consulting Services, Inc.; Retired Partner, Accenture PLC Ireland; and Member of the Board of Directors for several not-for-profit organizations Mr. Kabat has been a director of the Company since May 1996. Mr. Kabat joined Andersen Consulting (now Accenture PLC Ireland) in 1960 and became a partner in 1970. He specialized in management organization, financial information systems, and Change Management Services until he retired in 1992. From 1992 to 2006, Mr. Kabat was the President of DJK Consulting Services, Inc., where he worked with a limited number but diverse range of clients. From 1992 to 1995, he served as the Chief Financial Officer of Central Park Skaters, Inc. From 1992 to 1997, he served as the Chief Financial Officer of Blades Board and Skate, LLC, a retail chain of specialty sporting goods. During his consulting career with Andersen Consulting, Mr. Kabat helped launch an entirely new practice specialty called Change Management Services. He was the recipient of the "Bravos" award for outstanding contribution to the Change Management practice. He has made numerous speeches, written articles and contributed chapters to specialized books (e.g., Budgeting: Key to Planning and Control; Management Controls for Professional Firms; and The Change Management Handbook.) Mr. Kabat received his bachelor's degree from Antioch College and a master's degree from Columbia University School of Business. He majored in accounting, became a Certified Public Accountant and joined Andersen Consulting after serving in the United States Army. Mr. Kabat's other board affiliations include Phoenix House Development Fund and the L'Aquila Property Owners Association. Former Chief Financial Officer of United Parcel Service, Inc. and Member of the Board of Directors of NCR Corporation Mr. Kuehn has been a director of the Company since May 2016. He was Chief Financial Officer of United Parcel Service, Inc. ("UPS"), a global leader in logistics, from 2008 until 2015. Prior to his appointment as CFO, Mr. Kuehn was Senior Vice President Worldwide Sales and Marketing, leading the transformation of the sales organization to improve the global customer experience. Mr. Kuehn was UPS's first Vice President of Investor Relations, taking the company public in 1999 in one of the largest IPOs in U.S. history. Since he joined UPS as a driver in 1977, Mr. Kuehn's UPS career included leadership roles in sales and marketing, engineering, operations and strategic cost planning. Mr. Kuehn is also a director at NCR Corporation. He graduated from Yale University, received a Master of Business Administration from the University of Miami and completed an advanced management program from the Wharton School of Business. Lead Director, Henry Schein, Inc., Retired Chairman, Ernst & Young, LLP (now known as EY LLP), and Member of the Board of Directors of Lazard Ltd. and Loews Corporation Mr. Laskawy has been a director of the Company since February 2002, and has served as Lead Director since March 2012. Mr. Laskawy spent 40 years at Ernst & Young (now known as EY LLP), retiring as Chairman and CEO of the Company in 2001. Under his leadership, the firm expanded into a global leader in assurance, tax, transaction and advisory services. Today, there are 141,000 people worldwide. Mr. Laskawy joined Ernst & Young in 1961 after graduating from the Wharton School of the University of Pennsylvania with a Bachelor's degree in Economics. Progressing through the ranks of the audit services practice, he was admitted to the firm's partnership in 1971. He became Managing Partner of the New York Office in 1981, and in 1985 was named Vice Chairman and Managing Partner of the New York Region and a member of the firm's Management Committee. Mr. Laskawy became Chairman and CEO of Ernst & Young in 1994 and held that position until his retirement. Mr. Laskawy also serves on the Board of Directors of Capgemini Services SAS, Lazard Ltd, and Loews Corporation. In September 2008 he was appointed non-executive Chairman of Fannie Mae. He has served as both Chairman and Vice Chairman of the International Accounting Standards Committee Foundation, which oversees the setting of accounting standards in over 100 countries. He was a member of the Independence Standards Board, created by the Securities and Exchange Commission, and the American Institute of Certified Public Accountants to review and update rules regarding auditor independence, and the 1999 Blue Ribbon Committee on Improving the Effectiveness of Corporate Audit Committees. Executive Vice President, Chief Strategic Officer, Member of the Board of Directors Mr. Mlotek, now in his 21st year with Henry Schein, Inc., currently serves as Executive Vice President and Chief Strategic Officer, a position he has held since 2012. He is a member of the Company's Executive Management Committee and a member of the Company's Board of Directors. In his current role, Mr. Mlotek has three main priorities: worldwide merger and acquisition activity for the Company; business development, including important supplier partnership arrangements; and worldwide strategic planning. Prior to holding his current position, Mr. Mlotek served as the Company's Senior Vice President of Corporate Business Development, and before that, upon joining the Company in 1994, was Vice President, General Counsel, and Secretary. Prior to joining Henry Schein, Mr. Mlotek was a partner in the law firm of Proskauer Rose, LLP and counsel to the Company, specializing in mergers and acquisitions, corporate reorganizations and tax law. At Proskauer, since 1989, Mr. Mlotek worked very closely with Henry Schein on various corporate matters. Prior to joining Proskauer, Mr. Mlotek was a partner in the law firm of Feit & Ahrens. Mr. Mlotek graduated from the Columbia University School of Law with high honors in 1980. He received an LL.M. in Taxation from New York University School of Law in 1985, also graduating with honors. Mr. Mlotek graduated summa cum laude with a B.S. degree in accounting from the Herbert Lehman University of City College of New York in 1977. Mr. Mlotek has been active in various charitable organizations, many of which help the perpetuation of the Yiddish language and culture. From 1996-2000, he served on the Conference of Presidents of Major American Jewish Organizations. Mr. Mlotek is a member of the New York State Bar Association. Executive Vice President, Chief Financial Officer, Member of the Board of Directors Now in his 28th year with Henry Schein, Inc., Mr. Paladino has held the position of Executive Vice President and Chief Financial Officer at Henry Schein since 2000, and has been Chief Financial Officer since 1993. Mr. Paladino is a member of the Company's Board of Directors and the Executive Management Committee. From 1990 to 1992, Mr. Paladino served as Vice President and Treasurer for Henry Schein, Inc., and from 1987 to 1990, he served as Corporate Controller. A certified public accountant, he was with BDO Seidman, LLP (now known as BDO USA, LLP) as Manager, General Audit and Consulting Services prior to joining Henry Schein in 1987. Mr. Paladino's responsibilities include the corporate oversight of business units, as well as direct responsibility for Corporate Finance. These corporate services include Financial Reporting, Financial Planning, Treasury, Investor Relations, Internal Audit, Risk Management and Taxation. He also has responsibility for Henry Schein Financial Services, which provides financial business services to Henry Schein's customers and works with Henry Schein's Corporate Business Development Group on Mergers and Acquisition activities. Mr. Paladino led the Company through the corporate reorganization and separation from Schein Pharmaceutical in 1993 and through the IPO process in 1995. Currently, Mr. Paladino is a member of the American Institute of CPAs, NYS Society of CPAs and the Institute of Management Accountants. He is also a Nasdaq Listing and Hearing Review Council member. The primary function of the Listing and Hearing Review Council is to provide advice to the Board of Directors of The Nasdaq Stock Market LLC on issues relating to listing rule and policy changes and enhancements that will protect investors and the integrity of the Nasdaq Stock Market; and to ensure the consistent and fair application and enforcement of the listing rules, procedures, and policies of Nasdaq. He is also a member of the Board of Directors for MSC Industrial Supply Co., a leading distributor of Metalworking and Maintenance, Repair and Operations products and services to industrial customers throughout North America. Mr. Paladino is the recipient of the 2013 Long Island Business News CFO Lifetime Achievement Award; ranked third on the 2009 and 2012 Institutional Investor Award List— Best CFO Award—Health Care Technology and Distribution Sector; and the recipient of the 1996 Financial Executive of the Year—IMA Award. Mr. Paladino holds a Bachelor of Business Administration degree from Bernard M. Baruch College. Senior Advisor for Manatt Health Solutions; Former President and CEO, Visiting Nurse Service of New York; Member of the Board of Directors of the New York eHealth Collaborative Ms. Raphael has been a director of the Company since August 2012. From 1989 to 2011, Ms. Raphael served as President and Chief Executive Officer of Visiting Nurse Service of New York (VNSNY), the largest nonprofit home health agency in the United States. As CEO, Ms. Raphael expanded the organization's services and launched innovative models of care for complex populations with chronic illness. Prior to joining VNSNY, Ms. Raphael held executive positions at Mt. Sinai Medical Center and in New York City government. Ms. Raphael was an Advanced Leadership Fellow at Harvard University in 2012. She chairs the New York eHealth Collaborative, a public-private partnership working to advance the adoption of health information technology in New York State. She is the Chair of the Long-Term Quality Alliance, Senior Advisor for Manatt Health Solutions, a member of the National Quality Forum Coordinating Committee, where she chairs its Post Acute/Long-Term Care Workgroup, and is a strategic advisor to the National Committee on Quality Assurance (NCQA). Ms. Raphael is a nationally recognized industry leader and an expert on health care policy. She has served on numerous commissions including the Medicare Payment Advisory Commission, the New York State Hospital Review and Planning Council and several Institute of Medicine committees. She was a member of New York State Governor Cuomo's Medicaid Redesign Team. In March 2013, Ms. Raphael was appointed by President Obama as a member of the Commission on Long-Term Care. Ms. Raphael also has served on numerous boards including those of Lifetime Blue Cross/Blue Shield, Barrier Therapeutics, Inc., Future Health, and the American Foundation for the Blind. She serves on the boards of the Primary Care Development Corporation, Pace University, and the Medicare Rights Center. She also is a member of several advisory boards including the Harvard School of Public Health's Health Policy Management Executive Council, the New York City Health and Mental Hygiene Advisory Council, and the New York City Age-Friendly Commission. Ms. Raphael has an MPA from Harvard University's Kennedy School and co-edited the book Home Based Care for a New Century. She was a Visiting Fellow at the Kings Fund in the United Kingdom, and was listed in Crain's New York Business 50 Most Powerful Women in New York City. Former Dean of the Dental Institute at King's College London and Professor of Orthodontics; Former Professor of Orthodontics, Senior Vice Provost of Engineering Technology and Provost of Polytechnic Institute at New York University Dr. Rekow has been a director of the Company since June 2014, and most recently served as the Dean of the Dental Institute at King's College London and Professor of Orthodontics from 2012 through 2016. From 2002 to 2012, Dr. Rekow was a Professor of Orthodontics at New York University (NYU), during which time she was Senior Vice Provost of Engineering Technology at NYU (2008 to 2012) and was Provost of Polytechnic Institute of NYU (2009 to 2012). Dr. Rekow has been President of both the International Association for Dental Research and the American Association of Dental Research and, since 2000, has been an American Dental Association Consultant to the Council on Scientific Affairs. In 2011, she was elected to the Faculty of Dental Surgery of the Royal College of Surgeons (England). Dr. Rekow is an internationally known authority on the performance of new materials and products for use in aesthetic and restorative dentistry and was one of the early pioneers in digital dentistry, capitalizing on her engineering education and industry experience. Dr. Rekow's team has also carried out research into the use of bio-engineered tissue to facilitate bone replacement in people who have been disfigured by disease or developmental defects. Dr. Rekow holds a number of patents in the dental field and is the author of, or contributor to, more than one hundred publications. Former CEO, Reliant Pharmaceuticals and Former President of U.S. Human Health for Merck & Co., Member of the Board of Directors of Honeywell International and The Progressive Corporation Dr. Sheares has been a director of the Company since January 2010. Dr. Sheares most recently served as Chief Executive Officer of Reliant Pharmaceuticals, Inc., a pharmaceutical company with integrated sales, marketing and development expertise that marketed a portfolio of branded cardiovascular pharmaceutical products, leading that company from January 2007 through its acquisition by GlaxoSmithKline plc in December 2007. Prior to joining Reliant, Dr. Sheares served as President of U.S. Human Health for Merck & Co., Inc. from March 2001 until July 2006, the culmination of a 19-year career with that company. Dr. Sheares is the former chair of the Board of Directors of the National Pharmaceutical Council, which focuses on broadly communicating the economic, clinical and societal value of pharmaceuticals. Dr. Sheares holds a bachelor's degree in chemistry from Fisk University and earned his doctorate in biochemistry from Purdue University. He completed his postdoctoral training as a Lucille P. Markey Scholar and a National Institutes of Health Postdoctoral Fellow at the Massachusetts Institute of Technology. Dr. Sheares also serves as a director of Honeywell International Inc., a diversified technology and manufacturing company; The Progressive Corporation, one of the nation's largest insurance holding companies; and Covance Inc., one of the world's largest and most comprehensive drug development companies.